Ensign Peak Advisors »

Bicara Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.8M 401k 16.83

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Oracle Corporation (ORCL)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Ensign Peak Advisors

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
State Street Corporation
Franklin Resources
Blackstone Group
Millennium Management

View all funds holding Bicara Therapeutics